Funding · Company
Octave Bioscience Inc
Menlo Park, CAHealthcare
Octave Bioscience Inc of Menlo Park, CA has disclosed $64M across 2 Form D offerings filed with the SEC between Nov 24, 2023 and Mar 24, 2025.
$64M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$32M
Form D · Mar 24, 2025 ↗
Q1 2025
· target $54M
$33M
Form D · Nov 24, 2023 ↗
Q4 2023
· target $38M
Filing details
HeadquartersMenlo Park, CAIndustryHealthcare (Other Health Care)SEC CIK0001702278Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →